We use cookies to make your visit to our website as pleasant as possible. If you continue to use the website, you agree to our privacy policy and to the use of cookies. More information about cookies and how ImpediMed uses them is available here.
Accept

Newsroom

Check out the latest news about our products and technologies, clinical trials, partnerships, and financials.

News Archive:

Press releases

ASX announcements, Press release
May 25, 2021

Official Release of SOZO Version 4.0 Software

View Content
ASX announcements, Press release
May 4, 2021

American College of Cardiology (ACC) Abstract Demonstrates Potential of SOZO in Heart Failure

View Content
ASX announcements, Press release
April 22, 2021

FDA Clearance for SOZO Heart Failure Index (HF-Dex™)

View Content
ASX announcements, Press release
April 8, 2021

SOZO Clinical Utility in Heart Failure Published

View Content
ASX announcements, Press release
March 4, 2021

ImpediMed Achieves Milestone 200,000 SOZO Patient Tests

View Download
ASX announcements, Press release
February 12, 2021

American College of Cardiology Accepts SOZO HF Abstract

View Download
ASX announcements, Press release
January 11, 2021

PREVENT Trial Finishes – Final Patient Completes Follow-up

View Download
ASX announcements, Press release
December 17, 2020

ImpediMed Secures HITRUST Certification

View Download
ASX announcements, Press release
November 30, 2020

Meta-Analysis: BIS L-Dex Statistically Significant Reduction in Lymphoedema

View Download
ASX announcements, Press release
November 19, 2020

NSW Health Further Expands Lymphoedema Prevention Program

View Download
ASX announcements, Press release
November 18, 2020

ImpediMed Secures First Commercial Heart Failure Sales

View Download
ASX announcements, Press release
November 9, 2020

AstraZeneca Selects SOZO for Second Large Renal Trial

View Download